Semin Hear 2015; 36(03): 111-121
DOI: 10.1055/s-0035-1555115
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Impact of Age on Cognition

Daniel L. Murman
1   Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2015 (online)


This article reviews the cognitive changes that occur with normal aging, the structural and functional correlates of these cognitive changes, and the prevalence and cognitive effects of age-associated diseases. Understanding these age-related changes in cognition is important given our growing elderly population and the importance of cognition in maintaining functional independence and effective communication with others. The most important changes in cognition with normal aging are declines in performance on cognitive tasks that require one to quickly process or transform information to make a decision, including measures of speed of processing, working memory, and executive cognitive function. Cumulative knowledge and experiential skills are well maintained into advanced age. Structural and function changes in the brain correlate with these age-related cognitive changes, including alterations in neuronal structure without neuronal death, loss of synapses, and dysfunction of neuronal networks. Age-related diseases accelerate the rate of neuronal dysfunction, neuronal loss, and cognitive decline, with many persons developing cognitive impairments severe enough to impair their everyday functional abilities. There is emerging evidence that healthy lifestyles may decrease the rate of cognitive decline seen with aging and help delay the onset of cognitive symptoms in the setting of age-associated diseases.

  • References

  • 1 Vincent GK, Velkoff VA, Bureau USC. The next four decades: the older population in the United States: 2010 to 2050. Washington, DC: U.S. Dept. of Commerce, Economics and Statistics Administration, U.S. Census Bureau; 2010. Available at: . Accessed on June 3, 2015
  • 2 Alzheimer's A ; Alzheimer's Association. 2014 Alzheimer's disease facts and figures. Alzheimers Dement 2014; 10 (2) e47-e92
  • 3 Harada CN, Natelson Love MC, Triebel KL. Normal cognitive aging. Clin Geriatr Med 2013; 29 (4) 737-752
  • 4 Salthouse TA. Selective review of cognitive aging. J Int Neuropsychol Soc 2010; 16 (5) 754-760
  • 5 Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994; 6 (1) 63-68
  • 6 Lezak MD, Howieson DB, Bigler ED, Tranel D. Neuropsychological Assessment. 5th ed. New York, NY: Oxford University Press; 2012
  • 7 Salthouse T. Consequences of age-related cognitive declines. Annu Rev Psychol 2012; 63: 201-226
  • 8 Sommers MS. Speech perception in older adults: the importance of speech-specific cognitive abilities. J Am Geriatr Soc 1997; 45 (5) 633-637
  • 9 Wong PC, Ettlinger M, Sheppard JP, Gunasekera GM, Dhar S. Neuroanatomical characteristics and speech perception in noise in older adults. Ear Hear 2010; 31 (4) 471-479
  • 10 Critchley M. And all the daughters of musick shall be brought low. Language function in the elderly. Arch Neurol 1984; 41 (11) 1135-1139
  • 11 Raz N, Gunning FM, Head D , et al. Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cereb Cortex 1997; 7 (3) 268-282
  • 12 Salat DH, Kaye JA, Janowsky JS. Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. Arch Neurol 1999; 56 (3) 338-344
  • 13 Madden DJ, Spaniol J, Costello MC , et al. Cerebral white matter integrity mediates adult age differences in cognitive performance. J Cogn Neurosci 2009; 21 (2) 289-302
  • 14 Dennis EL, Thompson PM. Functional brain connectivity using fMRI in aging and Alzheimer's disease. Neuropsychol Rev 2014; 24 (1) 49-62
  • 15 Pannese E. Morphological changes in nerve cells during normal aging. Brain Struct Funct 2011; 216 (2) 85-89
  • 16 Morrison JH, Hof PR. Life and death of neurons in the aging brain. Science 1997; 278 (5337) 412-419
  • 17 Terry RD, Masliah E, Salmon DP , et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30 (4) 572-580
  • 18 Masliah E, Mallory M, Hansen L, DeTeresa R, Terry RD. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 1993; 43 (1) 192-197
  • 19 Terry RD, Katzman R. Life span and synapses: will there be a primary senile dementia?. Neurobiol Aging 2001; 22 (3) 347-348 , discussion 353–354
  • 20 Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002; 8 (3) 448-460
  • 21 Richards M, Deary IJ. A life course approach to cognitive reserve: a model for cognitive aging and development?. Ann Neurol 2005; 58 (4) 617-622
  • 22 Morrison JH, Baxter MG. The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci 2012; 13 (4) 240-250
  • 23 Brier MR, Thomas JB, Snyder AZ , et al. Unrecognized preclinical Alzheimer disease confounds rs-fcMRI studies of normal aging. Neurology 2014; 83 (18) 1613-1619
  • 24 Steffener J, Brickman AM, Habeck CG, Salthouse TA, Stern Y. Cerebral blood flow and gray matter volume covariance patterns of cognition in aging. Hum Brain Mapp 2013; 34 (12) 3267-3279
  • 25 Maillet D, Rajah MN. Association between prefrontal activity and volume change in prefrontal and medial temporal lobes in aging and dementia: a review. Ageing Res Rev 2013; 12 (2) 479-489
  • 26 Sonnen JA, Larson EB, Crane PK , et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007; 62 (4) 406-413
  • 27 Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007; 69 (24) 2197-2204
  • 28 Boyle PA, Yu L, Wilson RS, Schneider JA, Bennett DA. Relation of neuropathology with cognitive decline among older persons without dementia. Front Aging Neurosci 2013; 5: 50
  • 29 Boyle PA, Wilson RS, Yu L , et al. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol 2013; 74 (3) 478-489
  • 30 Evans DA, Funkenstein HH, Albert MS , et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989; 262 (18) 2551-2556
  • 31 Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB ; Alzheimer's Disease Neuroimaging Initiative. What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus. Prog Neurobiol 2014; 117: 20-40
  • 32 Morris JC, Price JL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 2001; 17 (2) 101-118
  • 33 Gauthier S, Reisberg B, Zaudig M , et al; International Psychogeriatric Association Expert Conference on mild cognitive impairment. Mild cognitive impairment. Lancet 2006; 367 (9518) 1262-1270
  • 34 Bateman RJ, Xiong C, Benzinger TL , et al; Dominantly Inherited Alzheimer Network. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012; 367 (9) 795-804
  • 35 Sperling RA, Aisen PS, Beckett LA , et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7 (3) 280-292
  • 36 Dubois B, Feldman HH, Jacova C , et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol 2014; 13 (6) 614-629
  • 37 Roe CM, Fagan AM, Grant EA , et al. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology 2013; 80 (19) 1784-1791
  • 38 Jack Jr CR, Wiste HJ, Weigand SD , et al. Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study. Lancet Neurol 2014; 13 (10) 997-1005
  • 39 Fotuhi M, Do D, Jack C. Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol 2012; 8 (4) 189-202
  • 40 Bano D, Agostini M, Melino G, Nicotera P. Ageing, neuronal connectivity and brain disorders: an unsolved ripple effect. Mol Neurobiol 2011; 43 (2) 124-130
  • 41 Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev 2008; (2) CD005381
  • 42 Carvalho A, Rea IM, Parimon T, Cusack BJ. Physical activity and cognitive function in individuals over 60 years of age: a systematic review. Clin Interv Aging 2014; 9: 661-682
  • 43 Willis SL, Tennstedt SL, Marsiske M , et al; ACTIVE Study Group. Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA 2006; 296 (23) 2805-2814
  • 44 Okonkwo OC, Schultz SA, Oh JM , et al. Physical activity attenuates age-related biomarker alterations in preclinical AD. Neurology 2014; 83 (19) 1753-1760
  • 45 Woods B, Aguirre E, Spector AE, Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev 2012; 2: CD005562